|
Home : Unsafe Drugs : Avandia : Newsfeeds : GlaxoSmithKline Q1 net profit up 14 pct GlaxoSmithKline Q1 net profit up 14 pct
Revenue fell 10 percent to 6.6 billion pounds, hit by a fall-off in sales of bird flu vaccine, a big seller a year ago, by generic competition for its Valtrex herpes drug and by regulatory curbs on sales of the diabetes drug Avandia. Excluding those drugs ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




